Oliver Van Oekelen

Company: Icahn School of Medicine, Mount Sinai

Job title: Physician-Scientist

Seminars:

Harnessing Synergy: Multi-Modal Approaches to Enhance CAR T-Cell Therapy in Multiple Myeloma 12:10 pm

• CAR-T cell therapy in multiple myeloma is currently not curative; an exhausted and immunosuppressive microenvironment contributes to resistance and relapse • Immunomodulatory agents activate T and NK cells as monotherapy and could be used to extend responses with limited downside • Multimodal treatment strategy can be applied to T cell-engaging therapies more broadlyRead more

day: Day One